Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 9 studies | 38% ± 9% | |
hepatocyte | 5 studies | 49% ± 23% | |
astrocyte | 5 studies | 32% ± 10% | |
glutamatergic neuron | 4 studies | 30% ± 10% | |
oligodendrocyte | 4 studies | 21% ± 4% | |
GABAergic neuron | 3 studies | 28% ± 8% | |
interneuron | 3 studies | 24% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 25% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5642.48 | 2640 / 2642 | 100% | 45.73 | 703 / 705 |
liver | 100% | 21744.00 | 226 / 226 | 97% | 80.43 | 394 / 406 |
breast | 99% | 6878.84 | 453 / 459 | 96% | 20.33 | 1069 / 1118 |
adrenal gland | 100% | 5657.01 | 257 / 258 | 93% | 20.18 | 213 / 230 |
prostate | 91% | 2091.48 | 222 / 245 | 99% | 20.62 | 498 / 502 |
thymus | 84% | 1208.14 | 549 / 653 | 96% | 30.28 | 582 / 605 |
kidney | 97% | 3990.64 | 86 / 89 | 79% | 13.19 | 713 / 901 |
skin | 77% | 1385.41 | 1397 / 1809 | 93% | 16.54 | 438 / 472 |
ovary | 86% | 1147.47 | 155 / 180 | 69% | 7.25 | 297 / 430 |
stomach | 80% | 1559.44 | 287 / 359 | 68% | 7.23 | 195 / 286 |
esophagus | 49% | 920.18 | 708 / 1445 | 90% | 25.20 | 164 / 183 |
uterus | 51% | 557.16 | 87 / 170 | 86% | 13.44 | 395 / 459 |
lung | 46% | 496.60 | 267 / 578 | 88% | 18.40 | 1011 / 1155 |
intestine | 45% | 805.07 | 433 / 966 | 73% | 7.58 | 386 / 527 |
pancreas | 30% | 302.27 | 97 / 328 | 84% | 8.47 | 150 / 178 |
bladder | 33% | 368.38 | 7 / 21 | 67% | 8.88 | 338 / 504 |
adipose | 99% | 8317.79 | 1192 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 21.77 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 94% | 13.08 | 75 / 80 |
muscle | 89% | 1542.18 | 712 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 70% | 1072.83 | 941 / 1335 | 0% | 0 | 0 / 0 |
heart | 35% | 378.22 | 300 / 861 | 0% | 0 | 0 / 0 |
spleen | 4% | 66.70 | 10 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.22 | 1 / 29 |
peripheral blood | 2% | 15.15 | 15 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006739 | Biological process | NADP metabolic process |
GO_0006734 | Biological process | NADH metabolic process |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0006090 | Biological process | pyruvate metabolic process |
GO_0044794 | Biological process | positive regulation by host of viral process |
GO_0019074 | Biological process | viral RNA genome packaging |
GO_0006094 | Biological process | gluconeogenesis |
GO_0019076 | Biological process | viral release from host cell |
GO_0006629 | Biological process | lipid metabolic process |
GO_0005739 | Cellular component | mitochondrion |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0042802 | Molecular function | identical protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004736 | Molecular function | pyruvate carboxylase activity |
GO_0009374 | Molecular function | biotin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PC |
Protein name | Alternative protein PC Pyruvate carboxylase Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) |
Synonyms | |
Description | FUNCTION: Pyruvate carboxylase catalyzes a 2-step reaction, involving the ATP-dependent carboxylation of the covalently attached biotin in the first step and the transfer of the carboxyl group to pyruvate in the second. Catalyzes in a tissue specific manner, the initial reactions of glucose (liver, kidney) and lipid (adipose tissue, liver, brain) synthesis from pyruvate. . |
Accessions | ENST00000393960.7 [P11498-1] ENST00000531614.6 L8E6S8 ENST00000524491.6 [P11498-2] A0A494BZT5 E9PRE7 ENST00000652125.1 [P11498-1] ENST00000628663.1 ENST00000528403.6 A0A494C101 ENST00000651036.1 [P11498-1] ENST00000393955.6 [P11498-1] P11498 ENST00000528224.2 ENST00000393958.7 [P11498-1] ENST00000651854.1 [P11498-1] ENST00000651469.1 A0A494C0T2 A0A494C016 ENST00000529047.6 [P11498-1] |